SCHEMBL22010964

SCHEMBL22010964

CCCCc1cc2oc3cc(OCC)c(F)c(F)c3c2c(F)c1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.37
ALDH1A1 P00352 10/20 0.37
HSD17B10 Q99714 7/20 0.37
GAA P10253 3/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
MAPT P10636 3/20 0.35
HTT P42858 2/20 0.35
HPGD P15428 7/20 0.34
NOD2 Q9HC29 1/20 0.32
PGAM1 P18669 2/20 0.32
TYR P14679 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
POLB P06746 2/20 0.31
USP2 O75604 1/20 0.31
ALOX15 P16050 1/20 0.31
RECQL P46063 1/20 0.31
BLM P54132 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22010811 0.96 KDM4E (0.36) KDM4EALDH1A1HSD17B10GAAMEN1
SCHEMBL22011226 0.91 HMGCR (0.36) KDM4EALDH1A1HSD17B10SMN1; SMN2MAPT
SCHEMBL22011095 0.87 PGAM1 (0.38) KDM4EALDH1A1HSD17B10MAPK1SMN1; SMN2
SCHEMBL22010799 0.86 PGAM1 (0.39) KDM4EALDH1A1HSD17B10HPGDPGAM1
SCHEMBL22011788 0.85 PGAM1 (0.42) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL20828855 0.85 ALDH1A1 (0.40) KDM4EALDH1A1HSD17B10GAAMEN1
SCHEMBL22011793 0.84 ALOX5 (0.41) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL22011810 0.84 ATM (0.32) KDM4EALDH1A1GAASMN1; SMN2MAPT
SCHEMBL22010968 0.84 PGAM1 (0.42) PGAM1L3MBTL1
SCHEMBL22010784 0.83 ABCB1 (0.34) KDM4EALDH1A1HSD17B10SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device YBX1, ZKSCAN2, RCC1 KDM4E 2962/4885ALDH1A1 577/4885HSD17B10 1585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.